Advanced Stage NSCLC
This frontal view x-ray of the chest shows advanced stage non-small cell lung cancer (NSCLC) of a 50-year-old woman with a long history of smoking and emphysema. The orange area depicts collapsed lung tissue at the base of the right lung, and the yellow area highlights a pleura-based density along the right hemithorax.
Fluorodeoxyglucose FDG-PET Scan
Fluorodeoxyglucose positron emission tomography (FDG-PET) scan of the chest (axial section) shows cancer in the right lung. The rapidly growing, highly metabolic cancer cells of the tumor take up the FDG, causing a distinguished appearance from the other lung tissue cells/benign tumors. FDG is useful in diagnosing, staging, and following tumors.
CT scan of the axial section of the thorax highlighting bronchopulmonary small cell lung cancer (SCLC) with a large middle mediastinum mass.
PET/CT Fusion Imaging
The PET/CT fusion image shows non-small cell lung cancer (NSCLC) of the right lung, with an early stage of another type of cancer showing up in the yellow/pink highlighted area. PET/CT fusion imaging is a multimodality technology that allows the correlation of findings from two concurrent imaging modalities.
3D CT Scan Model
Posterior view of a 3D CT scan model showing advanced non-small cell lung cancer (NSCLC) in a patient who had a long history of smoking and emphysema. The large pleura-based mass (green) has eroded through the ribs and thoracic vertebrae.
MRI Scan Showing SCLC
MRI scan of the abdomen highlighting small cell lung cancer (SCLC).
Lung Tumor Invading an Alveolus
Electron microscope using a colored scan to highlight a lung tumor (red) invading an alveolus. The cancer cells are covered with microvilli.
Masses in Both Lungs
Color coded chest x-ray showing masses (orange silhouettes) in both lungs.
Small Cell Lung Cancer
Colored coded chest x-ray highlighting small cell lung cancer (SCLC) represented in orange.
More people in the United States die from lung cancer than any other type of cancer. This is true for both men and women. According to the most currently available epidemiologic data from the US Centers for Disease Control and Prevention, 208,493 people were diagnosed with lung cancer in 2008, including 111,886 men and 96,607 women; among those, there were a total of 158,592 deaths from lung cancer. A recent report from the American Cancer Society estimates that there will be a total of 226,160 newly diagnosed cases of lung cancer in the US in 2012; of these, 160,340 will die of the disease.
- Chemo, Tamoxifen May Increase VTE Risk Among Patients With Breast Cancer
- Many Patients With HR+ Disease Receive Initial Palliative Chemotherapy, Despite Worse Outcomes
- Risk of Some Cancers Modestly Increased in Persons Who Had Herpes Zoster
- Different Types of Ovarian Cancer Have Different Causes
- Targeted Treatment Produces Rapid Shrinkage of Recurrent BRAF-mutant Brain Tumor
- Breastfeeding Associated With A Reduced Risk of Aggressive Breast Cancer
- Hospitals Should Enact Bereavement Programs, Researchers Urge
- Physical Activity Communications Should be Part of Oncology Care Clinic Visits With Patients
- Communication Practices of Many US Physicians May Be Discouraging HPV Vaccination
- Navigation Program Tackles Cancer Care on Two Fronts
- Suicides Significantly Higher Among Patients With Head and Neck Cancers
- No Racial Disparities in ODX Testing for Node-Negative Breast Cancer
- Weight Loss Counseling Effective in Breast Cancer Survivors
- Carpal Tunnel Syndrome Associated With Anastrozole for Prevention of Breast Cancer
- Existing Drug May Limit Recurrence and Metastasis of Glioblastoma Multiforme
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|